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Objective: For patients with symptomatic large volume benign prostate hyperplasia, open simple pros-
tatectomy has traditionally been the treatment of choice but laparoscopic simple prostatectomy (LSP) has
become an effective surgical option. Since the ﬁrst case of LSP was described in 2002, surgeons have
continued to expand the use of minimally invasive surgery. In 2008, the ﬁrst case of robotic simple
prostatectomy (RSP) was reported. We herein report our initial experience with robotic simple
prostatectomy.
Materials and methods: We performed retropubic robotic simple prostatectomy using a transperitoneal
approach in 10 patients. All of them had signiﬁcant symptomatic prostate enlargement conﬁrmed by
abdominal or transrectal ultrasound (mean 138.2 mL). Demographic data, perioperative outcomes, and
functional outcomes were recorded.
Results: The median age of patients was 68 years (range 60e76 years). The median International Prostate
Symptom Score at baseline was 24 (range 18e34). The median operation time was 150 minutes (range
130e180 minutes). The median estimated blood loss was 100 mL (range 50e850 mL). Intraoperative
blood transfusion was required in one patient (10%). The median resected prostate weight was 77.5 g
(range 60e120 g). The median hospital stay was 5 days (range 3e5 days). The median urethral cathe-
terization was 12 days (range 9e14 days). All of these patients gained signiﬁcant improvement in
maximum urine ﬂow rate (preoperative vs. postoperative 9.8 mL/min vs. 21.5 mL/min, p ¼ 0.001) and
postvoid residual urine (preoperative vs. postoperative 125 mL vs. 10 mL, p ¼ 0.001).
Conclusion: Robotic simple prostatectomy is a feasible alternative for a greatly enlarged prostate gland
with acceptable complications.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Benign prostatic hyperplasia (BPH) is the most common cause
of lower urinary symptoms in the aging male population. The
most common surgical intervention for BPH is transurethral
resection of the prostate. However, prolonged resection time can
lead to hemorrhage or transurethral resection syndrome. For pa-
tients who have a greatly enlarged prostate, open simple prosta-
tectomy (OSP) provides good long-term functional outcome.1
However, OSP was associated with a signiﬁcant risk of perioper-
ative complications and prolonged hospitalization.2,3 After thertment of Surgery, Taichung
ulevard, Section 4, Taichung,
ociation. Published by Elsevier Taﬁrst pure laparoscopic simple prostatectomy (LSP) described by
Mariano et al4 in 2002, several subsequent series demonstrated
encouraging outcomes.5 However, LSP did not gain popularity
among urologists because of its technical difﬁculties. In 2008,
Sotelo et al6 reported the ﬁrst case of robotic simple prostatec-
tomy (RSP). The steep learning curve associated with conventional
laparoscopy was overcome using the robotic system.7 Recently,
the minimally invasive approach has been used more frequently
in urologic surgery. Robot-assisted laparoscopic surgery is an
alternative surgical option with potential beneﬁts. In this report,
we describe our initial experience and evaluate the feasibility of
robot-assisted simple prostatectomy.
2. Materials and methods
Robotic simple prostatectomy was performed in 10 patients in
our institution. All of them had symptomatic benign prostateiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Table 2
Perioperative data.
Variable Mean Median Mode Range
Operation time (min) 146 150 150 130e180
Blood loss (mL) 208 100 100 50e850
Resected adenoma weight (g) 79 77.5 60 60e120
Hospitalization (d) 4.5 5 5 3e5
Catheterization (d) 11.6 12 13 9e14
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volume >80 mL, as estimated by either abdominal or transrectal
ultrasound. Five patients (50%) experienced urinary retention and
two patients (20%) were catheter dependent prior to the operation.
One patient (10%) experienced gross hematuria. All patients
received transrectal biopsy due to high prostate-speciﬁc antigen
(PSA) levels (range 4.5e60.6 ng/mL) and all biopsy specimens were
reported to be benign prostate hyperplasia cases. Preoperative
evaluation included medical history review, physical examination,
PSA test, International Prostate Symptom Score, uroﬂowmetry data,
and postvoid residual urine (PVR) test. For patients with hematuria,
preoperative urine cytology examination, intravenous pyelography,
and cystourethroscopy were performed for detection of urinary
lesions. Postoperative assessment included pathologic data, PSA,
uroﬂowmetry, and PVR.
2.1. Surgical technique
Each patient was given general anesthesia andwas positioned in
the steep Trendelenburg position. We used a four-arm da Vinci
surgical system with six ports and adapted the transperitoneal
approach. The bladder was mobilized using standard procedure
and Retzius' space was reached. Preprostate fat was cleared and the
anterior surface of the prostate was exposed. Two rows of hemo-
static sutures for control of the Santorini plexus were used. A
transverse capsular incision was made with electrocautery,
approximately 2 cm from the vesicoprostatic junction. Dissection of
the adenoma from the prostatic capsule was performed using ro-
botic curved scissors and blunt dissection. The bulging bilateral
lobes were enucleated separately. If a median lobe was present, it
was subsequently dissected while preserving a strip of the over-
lying mucosa. Lastly, the apical lobe was dissected and transected
from the point of the urethra carefully to avoid injury to the
external sphincter. The bladder neck mucosa was approximated to
the prostate apex using a 3-0 Monocryl suture to achieve retrigo-
nization. The anterior prostatic capsule was closed in a watertight
manner. A silicon Foley balloon was inﬂated with 40 mL of distilled
water and traction was applied.
3. Results
We successfully performed retropubic robotic simple prosta-
tectomy with a transperitoneal approach in 10 patients. The
baseline clinical characteristics of the 10 patients are presented
in Table 1. The perioperative outcomes are summarized in
Table 2. Robotic simple prostatectomy allows for a concomitant
procedure. In one of the 10 patients, right-side inguinal hernio-
plasty using mesh was performed. Two patients (20%) had ure-
thral catheter occlusion caused by blood clots, which required
recatheterization and bladder irrigation. Postoperative cystogramTable 1
Baseline clinical characteristics of patients.
Variable Mean Median Mode Range
Age (y) 67.9 68 68 60e76
BMI (kg/m2) 25 24.9 23.2 23.1e28.3
I-PSS preoperative (ng/mL) 25.1 24 18,24 18e34
PSA preoperative (ng/mL) 15.9 10.5 N/A 4.5e60.6
Estimated prostate volume (mL) 138.2 139 N/A 91e187
Qmax preoperative (mL/s) 9.9 9.8 9.8 5.9e13.1
PVR preoperative (mL) 127.3 122 N/A 100e184
BMI ¼ body mass index; I-PSS ¼ International Prostate Symptom Score; N/A ¼ not
available; PSA ¼ prostate-speciﬁc antigen; PVR ¼ postvoid residual urine;
Qmax ¼ maximum ﬂow rate.was routinely performed, which revealed a small leak in two
asymptomatic patients (20%) that required longer catheterization
(13 days and 14 days, respectively). Adenocarcinoma of the
prostate was identiﬁed in one patient (Gleason score 3 þ 3 ¼ 6,
tumor amount 1%). This patient received observation initially but
was lost to follow up after 1 year. Functional outcomes are shown
in Table 3. The median postoperative PSA was 0.58 ng/mL (range
0.13e1.42), indicating a 94% reduction compared with the pre-
operative PSA. Both postoperative Qmax and PVR showed signif-
icant improvement when compared with the preoperative
baseline data.4. Discussion
To select the appropriate surgical intervention for symptomatic
BPH, the size of the prostate gland is an important consideration.
For prostate adenoma <80 mL, transurethral resection of the
prostate is recognized as the standard of surgical treatment. For
patients with prostate adenoma larger than 80 mL, both OSP and
transurethral holmium laser enucleation are recommended by
European Association of Urology guidelines.8
In 1894, Eugene Fuller performed the ﬁrst suprapubic pros-
tatectomy and it was popularized by Peter Freyer in 1900.9 In
1945, Terence Millin ﬁrst performed retropubic simple prosta-
tectomy.10 The retropubic approach provides better prostate
exposure, direct visualization of prostate adenoma during
enucleation to ensure complete removal, direct visualization of
prostate fossa after enucleation to control bleeding, and precise
division of prostatic urethra to preserve urinary continence and
minimize bladder trauma. The suprapubic approach allows better
visualization of the bladder neck and ureteral oriﬁces, which is
suitable in patients with a protruding median lobe, concomitant
bladder diverticulum, and large bladder calculus. Retropubic
simple prostatectomy can be more challenging in patients with a
large median lobe. Incision was made over the overlying mucosa
at the level of bladder neck and the median prostate adenoma
was dissected carefully from bladder neck muscle. By preserving
the bladder neck, injury to the iatrogenic ureteral oriﬁces can be
avoided. In addition, prophylactic insertion of ureteral stents and
intravenous injection of indigo carmine dye could help identifyTable 3
Prostate-speciﬁc antigen, maximum ﬂow rate, and postvoid residual urine on follow
up.
Variables Mean Median Mode Range p
PSA preoperative (ng/mL) 15.9 10.5 N/A 4.5e60.6 0.014
PSA postoperative (ng/mL) 0.55 0.58 N/A 0.13e1.42
Qmax preoperative (mL/s) 9.9 9.8 9.8 5.9e13.1 0.001
Qmax postoperative (mL/s) 24.5 21.5 N/A 11.6e36.5
PVR preoperative, mL 180 125 N/A 100e430 0.001
PVR postoperative (mL) 14.3 10 10 6e29
N/A¼ not available; PSA¼ prostate-speciﬁc antigen; PVR¼ postvoid residual urine;
Qmax ¼ maximum ﬂow rate.
Table 4
Summary of reports of robotic simple prostatectomy published in recent years.
Year No. of
patients
Mean prostate
specimen weight (g)
Mean operation
duration (min)
Mean
hospitalization (d)
Mean
catheterization (d)
Mean blood
loss (mL)
Transfusion
rate (%)
Sotelo et al6 2008 7 50.6 205 1.4 7 298 14.3
Yuh et al12 2008 3 301 211 1.3 Not reported 558 33
John et al13 2009 13 82 210 6 6 500 0
Uffort et al14 2010 15 46.4 128.8 2.5 4.6 139.3 0
Sutherland et al15 2011 9 112 183 1.3 13 206 0
Matei et al16 2012 35 87 187 3.2 7.4 118 0
Vora et al17 2012 13 127 179 2.7 8.8 219 0
Leslie et al18 2014 25 88 214 4 9 143 4
Pokorny et al19 2015 67 84 97 4 3 200 1.5
This series 2015 10 79 146 4.5 11.6 208 10
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reported by Serretta et al2 in 2002, the overall complication rate
was 29%; 12% of their patients had severe bleeding and the
transfusion rate was 8.2%. In another multicenter study of 902
patients who underwent open simple prostatectomy, the overall
complication rate was 17% and the transfusion rate was 8%.3 LSP
is associated with decreased blood loss, limited pain, shorter
hospital stay, and no increase in postoperative complication
compared with open surgery.5 Since the ﬁrst robotic simple
prostatectomy was described in 2008,6 numerous groups have
reported their experience and results. In our review of the pub-
lished data on robotic simple prostatectomy, the presented re-
sults are comparable to those of other reports (Table 4).6,1219 In
our initial experience, blood transfusion was required in one
patient (10%). The transfusion rate of our group was higher due to
small case numbers. In the fourth case, injury to a prostate
capsular artery caused a total blood loss of 850 mL, which was
the highest among all patients. There was no need for blood
transfusion after this case. Our catheterization time was longer
compared with the times in previous studies. We prefer longer
postoperative catheterization time because we believe it might
help in tissue healing. Despite longer catheterization time, two of
our patients had some urine leakage, as shown on their post-
operative cystogram. A multi-institutional study of 1300 patients
who received robotic or LSP showed increasing numbers of ro-
botic surgery over time.20 Robotic simple prostatectomy can be
performed using either the transperitoneal or extraperitoneal
approach. The extraperitoneal approach in the robotic-assisted
radical prostatectomy was reported to be associated with less
bowel-related complications and less postoperative pain
compared with the transperitoneal approach.21 Transurethral
holmium laser enucleation of the prostate was also reported to
be an effective surgical option for a greatly enlarged prostate
gland.22 A randomized controlled trial comparing transurethral
laser enucleation and OSP for prostate glands larger than 100 g
showed that both procedures were equally effective, but laser
enucleation was associated with longer operation time, less
blood loss, shorter catheterization time, and shorter hospital stay
compared with OSP.23 Furthermore, transurethral laser enucle-
ation can be performed under spinal anesthesia but general
anesthesia is required in RSP.
In our institution, we performed robotic radical prostatectomy
in more than 300 cases before the ﬁrst robotic simple prosta-
tectomy without previous experience of LSP. Our results indicate
that the learning curve is short if surgeons are experienced in
robotic surgery. Although our results are favorable, some limi-
tations of our study should be considered, including small sam-
ple size, relatively short follow-up, and risk of selection bias.
Therefore, we cannot conﬁrm that the robotic approach is su-
perior to other minimally invasive methods. Randomized trialsthat compare the different surgical approaches and laser pros-
tatectomy are needed for conﬁrmation of long-term beneﬁts.
Although there is no general consensus about the ideal mini-
mally invasive approach for a greatly enlarged prostate gland, we
believe that robotic simple prostatectomy is a feasible
alternative.Conﬂicts of interest
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